Technology
Our pipeline forms a robust portfolio of investigational
therapies in varied stages of clinical development.

Technology

We are strengthening our pipeline based on novel platform technologies in 4 major fields: 1) LAPSCOVERYTM platform applied long-acting biologics pipeline; 2) PENTAMBODYTM enabling one antibody to combine with two targets; 3) Cancer Research mainly developing mutation-driven targeted therapies; and 4) IMD-New Formulation for fixed-dose combination programs.

LAPSCOVERYTM
A next generation long-acting platform technology
PENTAMBODYTM
Bispecific antibody platform technology
Cancer Research
Innovative anticancer combination therapies
IMD·New Formulation
Incrementally modified drugs & formulation technology